Market News

Market

Dow Jones Dips as UnitedHealth Tumbles: A Mixed Opening for US Markets Amid Earnings Season

US markets opened mixed with the Dow Jones under pressure from UnitedHealth's weak forecast. Earnings reports from Blackstone and American Express varied, while Netflix's results a...

Market

Dow Jones Dips as UnitedHealth Plummets: A Mixed Start for US Markets Amid Earnings Season

US markets opened mixed with the Dow Jones falling due to UnitedHealth's weak forecast, while Nasdaq and S&P 500 saw gains. Earnings reports from Blackstone and American Express va...

Market

European Markets Brace for Impact as ECB Prepares to Slash Rates Amid Economic Concerns

European markets are poised for a negative opening as the ECB is expected to cut interest rates again, amid concerns over the eurozone's economic performance due to global trade te...

Market

European Markets Dip at Opening: Earnings Reports and Economic Data Spark Early Trading Volatility

European stock markets opened lower on Thursday, affected by new economic data and earnings reports. German producer prices fell, while Switzerland reported a trade surplus. Key in...

Market

Dow Surges Over 370 Points as US Stock Futures Rally Following Powell's Keynote Address

US stock futures, including the Dow Jones, S&P 500, and Nasdaq 100, rallied early Thursday after Federal Reserve Chair Jerome Powell's speech, with the Dow gaining over 370 points....

Market

TSMC Shares Surge 4% Premarket as AI Chip Demand Drives Record Earnings

TSMC's US-based stocks rose 4% premarket after surpassing Q1 earnings forecasts with a 60.3% jump in net profit to $11.1 billion, driven by AI chip demand. The company maintains a ...

Market

UnitedHealth Shares Plunge 20% in Premarket Amidst Weak Forecast and Rising Costs

UnitedHealth Group Inc. shares plummet over 20% in premarket trading after revising its forecast due to rising medical costs among older adults, amidst leadership challenges and a ...

Market

Eli Lilly's Breakthrough Weight-Loss Pill Soars Stock by 13% in Premarket Trading

Eli Lilly's stock jumps 13% after announcing positive phase 3 results for orforglipron, a groundbreaking weight-loss and diabetes pill, marking a first in medical innovation with i...